Miracle Mile Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$294K Buy
3,853
+265
+7% +$19.1K ﹤0.01% 737
2025
Q4
$229K Buy
3,588
+186
+5% +$11.5K ﹤0.01% 801
2025
Q3
$214K Buy
3,402
+94
+3% +$6.56K ﹤0.01% 779
2025
Q2
$247K Buy
3,308
+483
+17% +$38K ﹤0.01% 636
2025
Q1
$249K Buy
2,825
+112
+4% +$10.6K 0.01% 557
2024
Q4
$248K Sell
2,713
-34
-1% -$3.49K 0.01% 560
2024
Q3
$308K Buy
2,747
+34
+1% +$3.4K 0.01% 423
2024
Q2
$266K Sell
2,713
-43
-2% -$4.27K 0.01% 428
2024
Q1
$276K Buy
+2,756
New +$242K 0.01% 418

Other funds holding EMN

Miracle Mile Advisors's EMN Position: Q1 2026 in Review

Miracle Mile Advisors increased its Eastman Chemical (EMN) stake by 7.4% in Q1 2026, buying an estimated $19.1K and bringing the position to 3,853 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Miracle Mile Advisors first reported a position in EMN in Q1 2024 and has held it in 9 quarters since. The position peaked at $308K in Q3 2024. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Miracle Mile Advisors held 3,853 shares of Eastman Chemical worth $294K as of Q1 2026.
  • Miracle Mile Advisors bought 265 Eastman Chemical shares in Q1 2026, an estimated $19.1K.
  • Eastman Chemical made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q1 2026, its #737 holding.
  • Miracle Mile Advisors first reported a position in Eastman Chemical in Q1 2024 and has held it in 9 quarters since.
  • Miracle Mile Advisors's Eastman Chemical position peaked at $308K in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.